Integra LifeSciences Holdings Corp. (IART) announced key executive leadership appointments, including the creation of a chief technology officer role to strengthen its innovation and growth strategy.
The company named Teshtar Elavia as corporate vice president and chief technology officer, a newly created position overseeing research and development and product innovation. Elavia brings more than 20 years of experience in medical technology and previously held senior R&D roles at Becton Dickinson, Eli Lilly, Medtronic and Johnson & Johnson.
Integra also appointed Michael Hutchinson as executive vice president, chief legal officer and secretary. He will lead global legal, compliance and ESG functions. Hutchinson most recently served as chief legal officer at LivaNova.
Kerri DiPietro was named corporate vice president and chief quality officer, responsible for leading the company's global quality organization and compliance initiatives. She joins from Haemonetics.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.